Health Library

Serum progesterone

Progesterone blood test (serum)

Serum progesterone is a test to measure the amount of progesterone in the blood. Progesterone is a hormone produced mainly in the ovaries.

Progesterone plays a key role in pregnancy. It is produced after ovulation, in the second half of the menstrual cycle. It helps make a woman's uterus ready for a fertilized egg to be implanted. It also prepares the uterus for pregnancy by inhibiting contraction of the uterine muscle and prepares the breasts for milk production.

I Would Like to Learn About:

How the Test is Performed

A blood sample is needed. Most of the time, blood is drawn from a vein located on the inside of the elbow or the back of the hand.

How to Prepare for the Test

Many medicines can interfere with blood test results.

• Your health care provider will tell you if you need to stop taking any medicines before you have this test.
• Do not stop or change your medicines without talking to your provider first.

How the Test will Feel

You may feel slight pain or a sting when the needle is inserted. You may also feel some throbbing at the site after the blood is drawn.

Why the Test is Performed

This test is done to:

• Determine if a woman is currently ovulating or has recently ovulated
• Evaluate a woman with repeated miscarriages (other tests are used more commonly)
• Determine the risk for miscarriage or ectopic pregnancy early in pregnancy, (now largely superseded by other diagnostic tests)

Normal Results

Progesterone levels vary, depending on the timing when the test is done. The blood progesterone level starts to rise midway through the menstrual cycle. It continues to rise for about 6 to 10 days, and then falls if the egg is not fertilized.

Levels continue to rise in early pregnancy.

The following are normal ranges based upon certain phases of the menstrual cycle and pregnancy:

• Female (pre-ovulation): less than 1 nanogram per milliliter (ng/mL) or 3.18 nanomoles per liter (nmol/L)
• Female (mid-cycle): 5 to 20 ng/mL or 15.90 to 63.60 nmol/L
• Male: less than 1 ng/mL or 3.18 nmol/L
• Postmenopausal: less than 1 ng/mL or 3.18 nmol/L
• Pregnancy 1st trimester: 11.2 to 90.0 ng/mL or 35.62 to 286.20 nmol/L
• Pregnancy 2nd trimester: 25.6 to 89.4 ng/mL or 81.41 to 284.29 nmol/L
• Pregnancy 3rd trimester: 48 to 150 to 300 or more ng/mL or 152.64 to 477 to 954 or more nmol/L

Normal value ranges may vary slightly among different labs. Talk to your provider about the meaning of your specific test results.

The examples above show the common measurements for results for these tests. Some labs use different testing methods, and thus the measurements may vary some.

What Abnormal Results Mean

Higher-than-normal levels may be due to:

• Pregnancy
• Ovulation
• Adrenal cancer (rare)
• Ovarian cancer (rare)
• Congenital adrenal hyperplasia (rare)

Lower-than-normal levels may be due to:

• Amenorrhea (no periods as result of anovulation [ovulation does not occur])
• Ectopic pregnancy
• Irregular periods
• Fetal death
• Miscarriage
• Thyroid disorders
• Elevated prolactin levels

Related Information

References

Bulun SE, Babayev E. Physiology and pathology of the female reproductive axis. In: Melmed S, Auchus, RJ, Goldfine AB, Rosen CJ, Kopp PA, eds. Williams Textbook of Endocrinology. 15th ed. Philadelphia, PA: Elsevier; 2025:chap 15.

Guber HA, Oprea M, Rusell YX. Evaluation of endocrine function. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 25.

Humphreys MA, Branch DW. Recurrent pregnancy loss. In: Lockwood CJ, Copel JA, Dugoff L, Louis J, Silver RM, Resnik R, eds. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 9th ed. Philadelphia, PA: Elsevier; 2023:chap 41.

Review Date: 5/22/2025  

Reviewed By: LaQuita Martinez, MD, Department of Obstetrics and Gynecology, Emory Johns Creek Hospital, Alpharetta, GA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- 2026 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.